Create Medic (5187) Q2 2025 earnings summary

Executive summary

• Net sales for the six months ended June 30, 2025, increased by 4.2% year-over-year to ¥6,564 million.

• Operating profit rose 88.3% year-over-year to ¥548 million, while ordinary profit grew 51.8% to ¥525 million.

• Profit attributable to owners of parent increased 73.9% year-over-year to ¥550 million.

Financial highlights

• Basic earnings per share for the six months was ¥61.35, up from ¥48.35 in the prior year period.

• Comprehensive income for the period was negative ¥157 million, compared to ¥1,411 million in the previous year.

• Total assets as of June 30, 2025, were ¥18,233 million, down from ¥20,047 million at December 31, 2024.

• Net assets decreased to ¥15,308 million from ¥15,750 million at year-end 2024.

• Capital adequacy ratio improved to 84.0% from 78.6% at the previous year-end.

Outlook and guidance

• Full-year 2025 net sales forecast at ¥13,583 million, up 4.2% year-over-year.

• Operating profit projected to rise 44.7% to ¥1,002 million; ordinary profit to increase 39.0% to ¥1,043 million.

• Profit attributable to owners of parent expected to decline 5.3% to ¥796 million.

• Basic earnings per share for the full year forecast at ¥92.67.